Sammy Saab
- Hepatology top 0.02%
- Liver Disease and Transplantation 148
- Hepatitis C virus research 147
- Hepatocellular Carcinoma Treatment and Prognosis 29
- Transplantation top 0.5%
- Renal Transplantation Outcomes and Treatments 17
- Epidemiology top 0.1%
- Liver Disease Diagnosis and Treatment 238
- Hepatitis B Virus Studies 96
- Surgery top 0.5%
- Organ Transplantation Techniques and Outcomes 78
- Pharmacology top 1%
-
- Alcohol Consumption and Health Effects 15
Sammy Saab
357 papers receiving 11.6k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Hepatology 9.0k
- Transplantation 780
- Epidemiology 7.4k
- Surgery 4.4k
- Pharmacology 340
Countries citing papers authored by Sammy Saab
This map shows the geographic impact of Sammy Saab's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sammy Saab with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sammy Saab more than expected).
Fields of papers citing papers by Sammy Saab
This network shows the impact of papers produced by Sammy Saab. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sammy Saab. The network helps show where Sammy Saab may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sammy Saab, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 4 | |
| 2 | 2023 | 7 | |
| 3 | 2023 | 12 | |
| 4 | 2023 | 3 | |
| 5 | 2021 | 11 | |
| 6 | 2018 | 7 | |
| 7 | Impact of Sustained Viral Response With Direct-Acting Agents on Glycemic Control and Renal Function in Hepatitis C Liver Transplant Recipients. | 2018 | 5 |
| 8 | 2017 | 36 | |
| 9 | 2017 | 12 | |
| 10 | 2016 | 3 | |
| 11 | 2016 | 15 | |
| 12 | 2016 | 14 | |
| 13 | 2015 | 57 | |
| 14 | 2015 | 12 | |
| 15 | 2014 | 52 | |
| 16 | 2014 | 62 | |
| 17 | 2011 | 43 | |
| 18 | Sorafenib as adjuvant therapy for high-risk hepatocellular carcinoma in liver transplant recipients: feasibility and efficacy. | 2010 | 42 |
| 19 | 2010 | 63 | |
| 20 | 2001 | 14 |
About Sammy Saab
Sammy Saab is a scholar working on Hepatology, Epidemiology, Transplantation, Surgery and Infectious Diseases, having authored 369 papers that have together received 11.8k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (238 papers), Liver Disease and Transplantation (148 papers), Hepatitis C virus research (147 papers), Hepatitis B Virus Studies (96 papers), Organ Transplantation Techniques and Outcomes (78 papers), Hepatocellular Carcinoma Treatment and Prognosis (29 papers), Renal Transplantation Outcomes and Treatments (17 papers) and Alcohol Consumption and Health Effects (15 papers). The work is most often cited by research in Hepatology (9.0k citations), Transplantation (780 citations), Epidemiology (7.4k citations), Surgery (4.4k citations) and Pharmacology (340 citations). Sammy Saab has collaborated with scholars based in United States, China and Italy. Frequent co-authors include Ronald W. Busuttil, Francisco Durazo, Myron J. Tong, Douglas G. Farmer, Eric Chak, Steven Han, Zobair M. Younossi, Hasan Yersiz, Leonard I. Goldstein and Jonathan R. Hiatt. Their work appears in journals such as Digestive Diseases and Sciences, Liver Transplantation, Liver International, Journal of Clinical Gastroenterology and Gastroenterology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.